Literature DB >> 11025555

Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?

C M Ryan1, M Geckle.   

Abstract

Review of the literature on the cognitive correlates and consequences of Type 2 diabetes reveals two very intriguing findings. Not only are verbal learning and memory skills most likely to be disrupted as compared to other cognitive skills (e.g. attention, executive function; psychomotor efficiency), but these mnestic deficits appear to be restricted to individuals with diabetes who are older than 60-65 years of age. Middle-aged adults with either Type 2 or Type 1 diabetes are apparently protected insofar as researchers have only infrequently reported learning and memory impairments in that age group. Why do older adults have such an increased risk of diabetes-associated memory dysfunction? In our view, this phenomenon is a consequence of a synergistic interaction between diabetes-related metabolic derangements and the structural and functional changes occurring in the central nervous system (CNS) that are part of the normal ageing process. To critically evaluate that possibility, we summarise what is known about learning and memory dysfunction in the adult with diabetes, examine the extent to which chronic hyperglycaemia may adversely affect the integrity of the CNS, and selectively review the literature on age-associated changes in brain morphology and cognitive function, paying special attention to the threshold theory of cognitive impairment. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11025555     DOI: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr141>3.0.co;2-x

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  47 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  Hippocampal infusions of pyruvate reverse the memory-impairing effects of septal muscimol infusions.

Authors:  Desiree L Krebs; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2005-09-27       Impact factor: 4.432

4.  Inhibition of synaptophysin ubiquitination may improve the intelligent drop due to high glucose and hypoxia.

Authors:  Qiang Li; Xiao-Long Zhu; Ai-Ping Jin; Xue-Yuan Liu; Yan-Xin Zhao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Authors:  Catherine M Bender; Susan M Sereika; Adam M Brufsky; Christopher M Ryan; Victor G Vogel; Priya Rastogi; Susan M Cohen; Frances E Casillo; Sarah L Berga
Journal:  Menopause       Date:  2007 Nov-Dec       Impact factor: 2.953

Review 6.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

7.  Exploring effects of type 2 diabetes on cognitive functioning in older adults.

Authors:  Sophie E Yeung; Ashley L Fischer; Roger A Dixon
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

8.  Intensive diabetes treatment and cognition: no long-lasting effects of recurrent hypoglycemia.

Authors:  Katie Weinger
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

9.  Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes.

Authors:  Ashley L Fischer; Cindy M de Frias; Sophie E Yeung; Roger A Dixon
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

10.  Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

Authors:  C Messier; M Gagnon
Journal:  Diabetologia       Date:  2009-09-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.